Irisin Mitigates Doxorubicin-Induced Cardiotoxicity by Reducing Oxidative Stress and Inflammation via Modulation of the PERK-eIF2α-ATF4 Pathway

Zhang Z, Yu X, Li J, Shen X, Fu W, Liu Y, Dong X, Wang Z

Drug Design, Development and Therapy 2025, 19:1067-1081

Published Date: 15 February 2025